2m 2m 2m 2m 2m 2m 2m
IMMUNIC (IMUX)
NASDAQ
$11.38-$0.04 (-0.39%)
Price as of Sep 11, 2026 7:30 PM EDT- $155.8MMarket Cap
- 43.77%1-Year Change
- BiotechnologyIndustry
IMMUNIC (IMUX)
$11.38-$0.04 (-0.39%)
IMUX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.42 | ||
Change | -$0.42 (-3.55%) | ||
Open | $11.93 | ||
High | $11.95 | ||
Low | $11.24 | ||
Previous Close | $11.84 | ||
Volume | 332,732 | ||
30-Day Average Volume | 265,137 | ||
1-Week Change | -12.89% | ||
1-Month Change | -26.23% | ||
1-Year Change | 43.77% | ||
3-Year Change | -25.36% | ||
5-Year Change | -87.89% | ||
Fundamentals | |||
Shares Outstanding | 13.6M | ||
Total Assets | $159.2M | ||
Market Cap | $155.8M | ||
Enterprise Value | $721,813.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.1M | ||
Free Cash Flow | -$31.2M | ||
EBIT | -$34.1M | ||
EBITDA | -$34.1M | ||
Net Working Capital | $126.6M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -14 | ||
PEG | -1 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/27/2026 | ||
Earnings & Revenue